These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 9184724)
1. Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis? Mitsumoto H Ann Pharmacother; 1997 Jun; 31(6):779-81. PubMed ID: 9184724 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Miller RG; Bouchard JP; Duquette P; Eisen A; Gelinas D; Harati Y; Munsat TL; Powe L; Rothstein J; Salzman P; Sufit RL Neurology; 1996 Oct; 47(4 Suppl 2):S86-90; discussion S90-2. PubMed ID: 8858057 [TBL] [Abstract][Full Text] [Related]
5. Riluzole: a new agent for amyotrophic lateral sclerosis. Wagner ML; Landis BE Ann Pharmacother; 1997 Jun; 31(6):738-44. PubMed ID: 9184716 [TBL] [Abstract][Full Text] [Related]
7. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs. Goyal NA; Mozaffar T Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719 [TBL] [Abstract][Full Text] [Related]
8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
9. Riluzole for amyotrophic lateral sclerosis. Drug Ther Bull; 1997 Feb; 35(2):11-2. PubMed ID: 9282413 [TBL] [Abstract][Full Text] [Related]
10. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Jaiswal MK Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496 [TBL] [Abstract][Full Text] [Related]
13. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lacomblez L; Bensimon G; Leigh PN; Guillet P; Meininger V Lancet; 1996 May; 347(9013):1425-31. PubMed ID: 8676624 [TBL] [Abstract][Full Text] [Related]
14. The impact of the approval of riluzole. Sufit R; Newman D Neurology; 1996 Oct; 47(4 Suppl 2):S117. PubMed ID: 8858065 [No Abstract] [Full Text] [Related]
15. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G; Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545 [TBL] [Abstract][Full Text] [Related]
16. The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III. Meininger V; Dib M; Aubin F; Jourdain G; Zeisser P J Neurol; 1997 May; 244 Suppl 2():S22-5. PubMed ID: 9178167 [TBL] [Abstract][Full Text] [Related]
17. Riluzole and amyotrophic lateral sclerosis: did potential market size bias pharmaceutical research? Riggs JE; Hobbs GR Arch Neurol; 1996 Nov; 53(11):1093-4. PubMed ID: 8912481 [No Abstract] [Full Text] [Related]
19. Riluzole for the treatment of amyotrophic lateral sclerosis. Saitoh Y; Takahashi Y Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483 [TBL] [Abstract][Full Text] [Related]
20. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000. Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]